MedPath

Jacla Research and Diagnostics Limited

πŸ‡¨πŸ‡¦Canada
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

8

Active:0
Completed:6

Trial Phases

4 Phases

Phase 2:1
Phase 3:1
Phase 4:1
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)β€’ Click on a phase to view related trials

Not Applicable
1 (25.0%)
Phase 2
1 (25.0%)
Phase 3
1 (25.0%)
Phase 4
1 (25.0%)

Repetitive Transcranial Magnetic Stimulation (rTMS) in MS Induced Spastic Paraparesis

Not Applicable
Recruiting
Conditions
Multiple Sclerosis
First Posted Date
2025-09-08
Last Posted Date
2025-09-12
Lead Sponsor
Clinique Neuro-Outaouais
Target Recruit Count
60
Registration Number
NCT07159789
Locations
πŸ‡¨πŸ‡¦

Clinique Neuro-Outaouais, Gatineau, Quebec, Canada

Efgartigimod in IVIG Dependent Myasthenia Gravis Patients

Phase 3
Recruiting
Conditions
Myasthaenia Gravis
Interventions
Drug: efgartigimod administration
First Posted Date
2025-01-09
Last Posted Date
2025-07-29
Lead Sponsor
Clinique Neuro-Outaouais
Target Recruit Count
30
Registration Number
NCT06765161
Locations
πŸ‡¨πŸ‡¦

Clinique Neuro-Outaouais, Gatineau, Quebec, Canada

Feasibility and Reliability of Multimodal Evoked Potentials in an International Multicenter Setting

Completed
Conditions
Multiple Sclerosis
First Posted Date
2017-02-09
Last Posted Date
2019-03-06
Lead Sponsor
Clinique Neuro-Outaouais
Target Recruit Count
14
Registration Number
NCT03047460
Locations
πŸ‡¨πŸ‡¦

Clinique Neuro-Outaouais, Gatineau, Quebec, Canada

Avelumab in Patients With Newly Diagnosed Glioblastoma Multiforme

Phase 2
Completed
Conditions
Glioblastoma Multiforme of Brain
Interventions
First Posted Date
2017-02-09
Last Posted Date
2025-05-25
Lead Sponsor
Clinique Neuro-Outaouais
Target Recruit Count
38
Registration Number
NCT03047473
Locations
πŸ‡¨πŸ‡¦

Clinique Neuro-Outaouais, Gatineau, Quebec, Canada

Motor Evoked Potentials as a Biomarker in Alemtuzumab Treated Multiple Sclerosis Patients

Completed
Conditions
Multiple Sclerosis
First Posted Date
2015-12-08
Last Posted Date
2021-07-28
Lead Sponsor
Clinique Neuro-Outaouais
Target Recruit Count
10
Registration Number
NCT02623946
Locations
πŸ‡¨πŸ‡¦

Clinique Neuro-Outaouais, Gatineau, Quebec, Canada

  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.